NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹13.39
-0.88%
NAV as on 18 Dec 24, 12:00 AM
very high risk
sector healthcare
equity
NAV as on 18 Dec 24, 12:00 AM
very high risk
sector healthcare
equity
0.00%p.a.
Last 1Y
0.00%p.a.
Last 3Y
0.00%p.a.
Last 5Y
32.00%p.a.
Since Inception
About WhiteOak Capital Pharma and Healthcare Fund Growth for NRIs
NRIs can achieve long-term capital appreciation by investing in the WhiteOak Capital Pharma and Healthcare Fund Growth scheme from WhiteOak Capital Asset Management Limited. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Feb 2024, WhiteOak Capital Pharma and Healthcare Fund Growth is Sector - Healthcare fund of its category with 254.08 Cr fund under management as on Dec 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.
- WhiteOak Capital Pharma and Healthcare Fund Growth delivered 0.0% annual returns during the last year. It has delivered 32.0% average annual returns since the fund was launched.
- WhiteOak Capital Pharma and Healthcare Fund Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
- The scheme has predominantly invested in equity
Fund Objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd
9.50%
Max Healthcare Institute Ltd Ordinary Shares
6.26%
Cipla Ltd
5.13%
Krishna Institute of Medical Sciences Ltd
3.37%
Lupin Ltd
3.35%
Fortis Healthcare Ltd
3.19%
Poly Medicure Ltd
2.85%
Strides Pharma Science Ltd
2.74%
Mankind Pharma Ltd
2.68%
Dr Reddy's Laboratories Ltd
2.46%
Fund Managers
- Piyush Baranwal (Feb 2024 - Present)
- Ramesh Mantri (Feb 2024 - Present)
- Dheeresh Pathak (Feb 2024 - Present)
- Naitik Shah (Apr 2024 - Present)
Key Information
View Scheme Document
WhiteOak Capital Pharma and Healthcare Fund Growth SIP Calculator
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
NRI Mutual Fund Tax on WhiteOak Capital Pharma and Healthcare Fund Growth
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
How can NRIs invest in WhiteOak Capital Pharma and Healthcare Fund Growth?
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
- Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
- PAN Number
- Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
- Passport – front and back
- Passport size photograph
- signature
If all details are correct, your KYC will be approved within 7 to 8 business days.
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in WhiteOak Capital Pharma and Healthcare Fund Growth
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
- City and country of birth
- NRE/NRO bank account statement/ canceled cheque for the latest 3 months
- Nominee details
Similar Funds
Funds
3Y Return
Nippon India Pharma Fund - Growth
very high risk | equity
20.9%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
very high risk | equity
25.9%
SBI Healthcare Opportunities Fund Growth
very high risk | equity
25.4%
Frequently Asked Questions
Copyright | 2021 @ SBNRI | All Rights Reserved